Comment
Author: Admin | 2025-04-28
Quetiapine (Seroquel) are the most sedating atypical antipsychotics.All antipsychotic medications contain a Boxed Warning about use in patients with dementia. Neither Vraylar nor Abilify are approved to treat such patients.There is a higher chance of death in older adults who take antipsychotics for mental health problems caused by dementia (dementia-related psychosis). Most of the deaths were linked to heart disease or infection.These medicines are not approved to treat mental health problems caused by dementia.Antidepressants increased the risk of suicidal thoughts and behaviors inpediatric and young adult patients. The safety and effectiveness of Vraylar havenot been established in children.A Boxed Warning is the most stringent prescription safety warning from the FDA.This is not a complete list of side effects, precautions and warnings associated with Vraylar, Abilify or other atypical antipsychotics. The types or incidence of side effects may be different for you. Discuss these topics with your doctor.Related questionsDoes Abilify cause weight gain?How long do Abilify withdrawal symptoms last?What antidepressants are usually taken with Abilify?Which is more effective - Vraylar or Abilify?Both Vraylar and Abilify have been shown in clinical trials to be effective for their approved uses. Ultimately, the decision of which drug to use may depend upon your condition, previous treatments, preferred formulation, side effects, cost and doctor preferences. For most patients, these drugs are well-tolerated and effective.Advantages with AbilifyAbilify is approved by the FDA to treat more types of mental health disorders when compared to Vraylar. For example, Abilify may be used in pediatric patients for Autistic disorder,
Add Comment